TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
BIO

Bio-Rad Laboratories Inc

Healthcare · Medical Devices

381.00$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Bio-Rad Laboratories Inc (BIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 10,252 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BIO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
4,020 3,851 3,953 4,143 4,186 4,273 4,272 6,386 6,719 5,611 6,863 7,647 7,177 8,009 8,684 10,097 12,021 12,973 13,933 15,118 19,953 17,799 14,374 12,682 12,058 13,502 13,667 11,978 11,896 12,299 12,610 9,688 10,603 9,364 9,527 10,214 9,696 10,577 9,790 10,252
1,850 1,845 1,733 1,827 1,892 1,977 1,977 1,992 2,034 2,023 2,032 2,088 2,048 2,180 2,083 2,133 2,324 2,140 2,175 2,289 2,466 1,990 3,303 3,250 3,140 3,158 3,277 3,139 3,147 3,048 3,061 3,056 3,056 3,030 3,037 2,811 2,842 2,906 2,942 3,021
418 456 292 322 329 384 384 403 435 432 456 581 561 661 604 608 840 662 673 733 860 471 802 597 518 434 464 390 458 404 433 407 410 488 521 369 398 532 507 517
806 839 674 713 716 761 761 818 861 850 859 982 979 1,115 1,037 1,032 1,154 991 1,020 1,161 1,337 870 2,073 1,968 1,850 1,791 1,851 1,723 1,759 1,607 1,646 1,616 1,622 1,665 1,660 1,374 1,421 1,543 1,565 1,619
368 372 373 393 420 465 465 404 382 392 392 378 356 393 380 370 402 419 408 399 418 424 464 450 432 495 498 492 457 489 445 446 462 453 425 470 474 473 426 442
556 525 560 581 602 595 595 591 601 584 590 590 588 554 557 628 640 622 605 599 589 572 605 657 686 719 753 777 776 781 783 804 804 760 790 799 783 741 771 781
475 489 505 503 501 493 500 490 484 509 503 499 496 499 486 679 678 491 679 672 681 696 684 656 633 499 681 688 711 – – – 719 689 682 740 721 710 – –
507 477 516 530 521 506 506 500 502 220 231 235 264 264 264 292 292 292 292 292 292 347 346 347 400 407 408 412 407 414 413 412 415 411 415 582 579 580 577 574
221 162 191 185 181 174 174 158 151 133 139 128 147 146 138 211 205 200 192 185 177 254 247 240 325 332 328 329 314 321 314 307 307 294 296 397 388 174 167 160
1,317 1,271 1,245 1,332 1,337 1,343 1,342 1,747 1,818 1,591 1,999 2,160 2,046 2,254 2,391 2,744 3,196 3,093 3,324 3,523 4,621 4,114 4,191 3,760 3,605 3,886 3,904 3,531 3,480 3,558 3,559 2,910 3,116 2,795 2,848 3,085 2,960 3,123 2,939 3,078
443 471 408 455 466 503 503 442 453 451 444 446 434 905 869 927 987 632 610 587 650 681 648 614 571 569 590 582 558 523 466 487 498 468 507 549 522 517 917 961
0.3 0.3 0.5 0.5 0.5 0.4 0.4 1.7 1.8 0.5 36 36 35 462 461 460 461 38 41 37 38 37 38 36 34 37 37 37 40 41 41 42 44 43 43 41 38 38 437 401
280 133 231 278 274 347 307 262 257 322 239 247 250 107 118 131 133 139 138 133 136 142 161 158 143 135 161 150 112 145 103 127 122 122 138 139 129 129 133 144
434 434 434 434 434 435 435 423 424 424 438 438 438 14 12 12 12 12 11 11 11 11 1,197 1,197 1,197 1,198 1,198 1,198 1,199 1,199 1,190 1,190 1,200 1,200 1,201 1,201 1,201 1,203 803 803
2,703 2,579 2,707 2,811 2,848 2,930 2,930 4,639 4,900 4,020 4,864 5,487 5,131 5,755 6,293 7,353 8,825 9,880 10,609 11,595 15,332 13,685 10,183 8,923 8,454 9,615 9,764 8,447 8,416 8,741 9,051 6,779 7,488 6,569 6,679 7,129 6,737 7,454 6,851 7,174
1,857 1,829 1,848 1,853 1,881 1,830 1,830 4,281 4,551 3,722 4,586 5,185 4,917 5,471 6,157 7,123 8,429 9,268 10,245 11,159 15,081 13,525 10,138 9,210 9,047 9,898 9,967 8,805 8,911 9,261 9,645 7,479 8,132 7,416 7,480 7,798 7,456 8,176 7,649 8,021
30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 30 29 29 29 29 28 28 28 28 27 27 27 27 27

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?